TK

Thomas Koestler

Member Board Of Directors at Arisaph Pharmaceuticals

Thomas Koestler has extensive experience in the healthcare sector, currently serving as the Executive Director of Vatera Health Care Partners since January 2010. In addition to this role, Thomas Koestler holds several prominent positions including Chairman of the Board for both Melinta Therapeutics and Edgemont Pharmaceuticals, as well as being a member of the Board of Directors for Momenta Pharmaceuticals, ImmusanT, Inc., and Arisaph Pharmaceuticals, Inc. Thomas Koestler has also served as a Scientific Advisor for Allergan and has participated on the Scientific Advisory Board for Forest Labs and Actavis. Previous experience includes serving on the Board of Directors for Novo Nordisk and Pearl Therapeutics, as well as holding the title of President at Schering-Plough Research Institute from 2003 to 2009. Thomas Koestler earned a Doctor of Philosophy (Ph.D.) in Pathology/Experimental Pathology/Medicine from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo between 1977 and 1982.

Links

Previous companies

Novo Nordisk logo

Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


  1. This content will be removed shortly.